BR0312547A - Inibidores virais - Google Patents
Inibidores viraisInfo
- Publication number
- BR0312547A BR0312547A BR0312547-5A BR0312547A BR0312547A BR 0312547 A BR0312547 A BR 0312547A BR 0312547 A BR0312547 A BR 0312547A BR 0312547 A BR0312547 A BR 0312547A
- Authority
- BR
- Brazil
- Prior art keywords
- viral inhibitors
- imidazo
- virus
- class
- relates
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- UBOOKRVGOBKDMM-UHFFFAOYSA-N 3h-imidazo[4,5-c]pyridine Chemical class C1=NC=C2NC=NC2=C1 UBOOKRVGOBKDMM-UHFFFAOYSA-N 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 abstract 1
- 241000710781 Flaviviridae Species 0.000 abstract 1
- 241000709664 Picornaviridae Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
"INIBIDORES VIRAIS". A presente invenção refere-se a uma composição farmacêutica para o tratamento ou prevenção de infecções virais compreendendo como um princípio ativo pelo menos um derivado de imidazo[4,5-c]piridina tendo a fórmula geral (Z): A invenção também refere-se aos processos para a preparação de compostos de acordo com a invenção tendo a fórmula geral mencionada acima e seu uso como um medicamento ou para tratar ou prevenir infecções virais.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0215293.2A GB0215293D0 (en) | 2002-07-03 | 2002-07-03 | Viral inhibitors |
GB0313251A GB0313251D0 (en) | 2003-06-10 | 2003-06-10 | Viral inhibitors |
PCT/BE2003/000117 WO2004005286A2 (en) | 2002-07-03 | 2003-07-03 | Viral inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0312547A true BR0312547A (pt) | 2005-04-26 |
BRPI0312547B1 BRPI0312547B1 (pt) | 2020-01-21 |
BRPI0312547B8 BRPI0312547B8 (pt) | 2021-05-25 |
Family
ID=30117086
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122018077110-0A BR122018077110B1 (pt) | 2002-07-03 | 2003-07-03 | derivados de imidazo [4,5-c]piridina, seus compostos e respectivas composições farmacêuticas |
BRPI0312547A BRPI0312547B8 (pt) | 2002-07-03 | 2003-07-03 | uso de derivados de imidazo [4,5-c]piridina como inibidores virais |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122018077110-0A BR122018077110B1 (pt) | 2002-07-03 | 2003-07-03 | derivados de imidazo [4,5-c]piridina, seus compostos e respectivas composições farmacêuticas |
Country Status (22)
Country | Link |
---|---|
US (2) | US7737162B2 (pt) |
EP (2) | EP1521754B1 (pt) |
JP (2) | JP4907082B2 (pt) |
KR (2) | KR101184032B1 (pt) |
CN (1) | CN1328279C (pt) |
AT (1) | ATE522528T1 (pt) |
AU (2) | AU2003243846B9 (pt) |
BR (2) | BR122018077110B1 (pt) |
CA (1) | CA2491243C (pt) |
CY (1) | CY1112042T1 (pt) |
DK (1) | DK1521754T3 (pt) |
EA (1) | EA013562B1 (pt) |
ES (2) | ES2525483T3 (pt) |
GB (1) | GB0215293D0 (pt) |
HK (2) | HK1082734A1 (pt) |
IL (1) | IL166055A (pt) |
MX (1) | MXPA04012965A (pt) |
NO (1) | NO330766B1 (pt) |
NZ (1) | NZ537473A (pt) |
PT (2) | PT1521754E (pt) |
SI (1) | SI1521754T1 (pt) |
WO (1) | WO2004005286A2 (pt) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
GB0215293D0 (en) * | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7511145B2 (en) | 2003-08-01 | 2009-03-31 | Genelabs Technologies, Inc. | Bicyclic heteroaryl derivatives |
SI1706403T1 (sl) * | 2003-12-22 | 2012-08-31 | Leuven K U Res & Dev | Imidazo(4,5-c)piridin spojine in postopki antivirusnega zdravljenja |
US20050222198A1 (en) * | 2003-12-22 | 2005-10-06 | K.U. Leuven Research & Development, Gerhard Puerstinger And Gilead Sciences, Inc. | Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
DK1718608T3 (da) | 2004-02-20 | 2013-10-14 | Boehringer Ingelheim Int | Virale polymeraseinhibitorer |
JP5014129B2 (ja) * | 2004-07-27 | 2012-08-29 | ギリアード サイエンシーズ, インコーポレイテッド | イミダゾ[4,5−d]ピリミジン、それらの使用および調製方法 |
ES2324794T3 (es) * | 2004-12-21 | 2009-08-14 | Gilead Sciences Inc | Imidazo(4,5-c)pyridine componente y metodo de tratamiento antiviral. |
US7763715B2 (en) | 2005-04-22 | 2010-07-27 | The Procter & Gamble Company | Extracting biopolymers from a biomass using ionic liquids |
MX2007014114A (es) | 2005-05-10 | 2008-03-14 | Intermune Inc | Derivados de piridona para modular el sistema de proteina cinasa activada por estres. |
WO2007014174A2 (en) * | 2005-07-25 | 2007-02-01 | Gilead Sciences, Inc. | Drug-resistant mutants of hepatitis c virus |
CA2618682C (en) | 2005-08-12 | 2011-06-21 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
PT2038275E (pt) * | 2006-07-07 | 2010-04-08 | Puerstinger Gerhard | Novo composto de piridazina e sua utilização |
US8263612B2 (en) | 2006-12-14 | 2012-09-11 | Gilead Sciences, Inc. | Viral inhibitors |
UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
UY31685A (es) * | 2008-03-04 | 2009-11-10 | Smithkline Beecham Corp | Compuestos antivirales, composiciones y metodos para usarlos |
GB0809314D0 (en) * | 2008-05-22 | 2008-07-02 | Summit Corp Plc | Compounds for treating muscular dystrophy |
JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン, インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
US20100204265A1 (en) * | 2009-02-09 | 2010-08-12 | Genelabs Technologies, Inc. | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections |
EP2519522B1 (en) * | 2009-12-30 | 2014-09-24 | ArQule, Inc. | Substituted imidazopyridinyl-aminopyridine compounds |
CA2797872A1 (en) | 2010-05-21 | 2011-11-24 | Gilead Sciences, Inc. | Heterocyclic flaviviridae virus inhibitors |
GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
JP6525437B2 (ja) | 2014-04-02 | 2019-06-05 | インターミューン, インコーポレイテッド | 抗線維性ピリジノン |
HRP20211456T1 (hr) | 2014-12-26 | 2021-12-24 | Emory University | Protuvirusni derivati n4-hidroksicitidina |
JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
SG11201808270PA (en) | 2016-03-31 | 2018-10-30 | Janssen Pharmaceuticals Inc | Substituted indoline derivatives as dengue viral replication inhibitors |
EP3436435B1 (en) | 2016-03-31 | 2021-05-12 | Janssen Pharmaceuticals, Inc. | Substituted indole derivatives as dengue viral replication inhibitors |
JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
MA44502A (fr) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals Inc | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
WO2017168333A1 (en) * | 2016-04-02 | 2017-10-05 | Shilpa Medicare Limited | Amifampridine dihydrochloride |
WO2017197036A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Spirocyclic degronimers for target protein degradation |
EP3455218A4 (en) | 2016-05-10 | 2019-12-18 | C4 Therapeutics, Inc. | C3 CARBON-BASED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION |
WO2017197055A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
KR102625988B1 (ko) | 2017-05-22 | 2024-01-16 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
KR102625991B1 (ko) | 2017-05-22 | 2024-01-16 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
JP6804790B1 (ja) | 2017-12-07 | 2020-12-23 | エモリー ユニバーシティー | N4−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 |
WO2021170600A1 (en) * | 2020-02-24 | 2021-09-02 | Katholieke Universiteit Leuven | Pyrrolopyridine and imidazopyridine antiviral compounds |
WO2021226261A1 (en) | 2020-05-06 | 2021-11-11 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
TW202241889A (zh) | 2020-12-23 | 2022-11-01 | 美商雅捷可斯治療公司 | 作為jak2抑制劑之6-雜芳基氧基苯并咪唑及氮雜苯并咪唑 |
CA3234638A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
Family Cites Families (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2191978A (en) * | 1935-10-10 | 1940-02-27 | Ig Farbenindustrie Ag | Quaternary nitrogen compounds and process of preparing them |
US2411662A (en) * | 1943-05-13 | 1946-11-26 | Geigy Ag J R | Imino-di-fatty acid amide |
US2548863A (en) * | 1946-05-29 | 1951-04-17 | Wyeth Corp | Substituted glycinamides |
US2516674A (en) * | 1948-10-29 | 1950-07-25 | Wyeth Corp | Substituted glycinamide |
US3985891A (en) * | 1973-02-03 | 1976-10-12 | Boehringer Ingelheim Gmbh | 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof |
SU813921A1 (ru) | 1979-10-26 | 1986-12-23 | Институт физико-органической химии и углехимии АН УССР | Стирильные производные имидазо(4,5- @ )пиридиний иодида,обладающие фунгицидной активностью |
SU851940A1 (ru) | 1980-03-20 | 1988-04-30 | Институт физико-органической химии и углехимии АН УССР | Четвертичные соли имидазо @ 4,5-с @ пиридини ,обладающие антимикробной и фунгистатической активностью |
SU860463A1 (ru) | 1980-04-09 | 1998-05-27 | Институт физико-органической химии и углехимии АН Украинской ССР | Производные 4-амино-1,3-диметилимидазо [4,5-с] пиридин-2-она, обладающие акарицидным действием |
SU1048742A1 (ru) | 1981-03-30 | 1986-12-23 | Институт физико-органической химии и углехимии АН УССР | 2,4-Дистирилпроизводные имидазо-(4,5- @ )пиридини ,обладающие бактериостатической и фунгистатической активностью |
US4358387A (en) * | 1981-08-10 | 1982-11-09 | Texaco Inc. | Cylinder lubricating oil composition |
US5137896A (en) | 1981-10-01 | 1992-08-11 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
CA1183847A (en) | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
FR2527608B1 (fr) * | 1982-05-28 | 1986-10-10 | Sandoz Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments |
ZA847926B (en) | 1983-10-17 | 1986-05-28 | Lilly Co Eli | 3-bicyclicpyridinium-methyl cephalosporins |
US4692443A (en) * | 1983-10-17 | 1987-09-08 | Eli Lilly And Company | 3-bicyclicpyridinium-methyl cephalosporins |
GB8501542D0 (en) * | 1985-01-22 | 1985-02-20 | Erba Farmitalia | 4 5 6 7-tetrahydro-imidazo(4 5-clpyridine derivatives |
GB8530602D0 (en) | 1985-12-12 | 1986-01-22 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
EP0232937B1 (en) | 1986-02-03 | 1992-08-19 | Janssen Pharmaceutica N.V. | Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
US4804658A (en) * | 1986-09-15 | 1989-02-14 | G. D. Searle & Co. | Imidazopyridine derivatives and pharmaceutical compositions |
US5057517A (en) * | 1987-07-20 | 1991-10-15 | Merck & Co., Inc. | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents |
NZ225447A (en) | 1987-07-20 | 1991-12-23 | Merck & Co Inc | Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions |
US5302601A (en) * | 1988-03-14 | 1994-04-12 | G. D. Searle & Co. | 5-substituted imidazo[4,5-c]pyridines |
US5227384A (en) | 1988-03-14 | 1993-07-13 | G. D. Searle & Co. | 5-substituted [4,5-c] imidazopyridines and pharmaceutical use thereof |
US4914108A (en) | 1988-03-14 | 1990-04-03 | G. D. Searle & Co. | 5-substituted(4,5-c)imidazopyridine compounds which have useful platelet activating factor antagonistic activity |
US5019581A (en) | 1988-03-14 | 1991-05-28 | G. D. Searle & Co. | 5-substituted (4,5-c) imidazopyridine compounds which have useful platelet activating factor antagonistic activity |
US5011382A (en) * | 1989-01-26 | 1991-04-30 | Thompson George A | Reciprocating piston pump |
US5332744A (en) * | 1989-05-30 | 1994-07-26 | Merck & Co., Inc. | Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists |
US4990518A (en) | 1989-09-13 | 1991-02-05 | G. D. Searle & Co. | Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines |
US4988707A (en) | 1989-09-13 | 1991-01-29 | G. D. Searle & Co. | Pharmacologically active phenylalkanoyl substituted imidazo (4,5-C) pyridines |
FR2663332B1 (fr) | 1990-06-15 | 1997-11-07 | Roussel Uclaf | Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus. |
US5011832A (en) | 1990-06-26 | 1991-04-30 | Merck & Co., Inc. | 2-biphenyl-carbapenem antibacterial agents |
US5372808A (en) * | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
JPH04327587A (ja) | 1991-04-26 | 1992-11-17 | Asahi Chem Ind Co Ltd | 6’−c−アルキル−3−デアザネプラノシンa誘導体、その製造法およびその用途 |
CA2111459A1 (en) | 1991-06-15 | 1992-12-23 | Choong S. Kim | Novel 3-fused pyridiniummethyl cephalosporins |
GB9116056D0 (en) | 1991-07-24 | 1991-09-11 | British Bio Technology | Compounds |
US5587372A (en) * | 1991-12-12 | 1996-12-24 | Roussel Uclaf | Cephalosporins |
GB9200245D0 (en) | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
GB9202792D0 (en) | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
GB9202791D0 (en) | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
DE4211474A1 (de) | 1992-04-06 | 1993-10-07 | Merck Patent Gmbh | Imidazopyridine |
US5208242A (en) | 1992-08-26 | 1993-05-04 | G. D. Searle & Co. | 5-substituted-4-phenyl-5H-imidazo[4,5-c]pyridine derivatives |
DE4230464A1 (de) | 1992-09-11 | 1994-03-17 | Merck Patent Gmbh | Imidazolderivate |
DE4236026A1 (de) * | 1992-10-24 | 1994-04-28 | Merck Patent Gmbh | Imidazopyridine |
BR9307570A (pt) | 1992-12-02 | 1999-05-25 | Pfizer | Diéteres de catecol como inibidores seletivos de pdeiv |
JP3115455B2 (ja) | 1992-12-18 | 2000-12-04 | 明治製菓株式会社 | 新規セファロスポリン誘導体 |
US5374638A (en) * | 1993-03-19 | 1994-12-20 | Merck & Co., Inc. | Six membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives used to treat asthma |
DE4309969A1 (de) | 1993-03-26 | 1994-09-29 | Bayer Ag | Substituierte heteroanellierte Imidazole |
KR100194994B1 (ko) | 1993-06-05 | 1999-06-15 | 손경식 | 새로운 세펨 화합물 |
DE4318813A1 (de) * | 1993-06-07 | 1994-12-08 | Merck Patent Gmbh | Imidazopyridine |
CZ288182B6 (en) | 1993-07-15 | 2001-05-16 | Minnesota Mining & Mfg | Imidazo[4,5-c]pyridine-4-amines and pharmaceutical preparations based thereon |
DE4324580A1 (de) * | 1993-07-22 | 1995-01-26 | Thomae Gmbh Dr K | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5486525A (en) | 1993-12-16 | 1996-01-23 | Abbott Laboratories | Platelet activating factor antagonists: imidazopyridine indoles |
WO1996001192A1 (en) | 1994-07-05 | 1996-01-18 | Asc Incorporated | Automobile sunroof assembly and control system |
US5563143A (en) | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
US6506876B1 (en) * | 1994-10-11 | 2003-01-14 | G.D. Searle & Co. | LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
US5585492A (en) * | 1994-10-11 | 1996-12-17 | G. D. Searle & Co. | LTA4 Hydrolase inhibitors |
US5635514A (en) | 1994-10-25 | 1997-06-03 | G. D. Searle & Company | Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors |
US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
HUT78019A (hu) * | 1995-03-31 | 1999-05-28 | András Horváth | Eljárás szubsztituált nitrogéntartalmú, heterociklusos vegyületek szintézisére |
US6063930A (en) * | 1996-04-03 | 2000-05-16 | Merck & Co., Inc. | Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors |
US6080870A (en) * | 1996-04-03 | 2000-06-27 | Merck & Co., Inc. | Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors |
US5859035A (en) * | 1996-04-03 | 1999-01-12 | Merck & Co., Inc. | Arylheteroaryl inhibitors of farnesyl-protein transferase |
US5872136A (en) * | 1996-04-03 | 1999-02-16 | Merck & Co., Inc. | Arylheteroaryl inhibitors of farnesyl-protein transferase |
US5854265A (en) * | 1996-04-03 | 1998-12-29 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
US5880140A (en) * | 1996-04-03 | 1999-03-09 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
US5883105A (en) * | 1996-04-03 | 1999-03-16 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5874452A (en) * | 1996-04-03 | 1999-02-23 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
US5939557A (en) * | 1996-04-03 | 1999-08-17 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6015817A (en) | 1996-12-05 | 2000-01-18 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP1035123B1 (en) * | 1997-11-28 | 2003-08-20 | Sumitomo Pharmaceuticals Company, Limited | Novel heterocyclic compounds |
DE19845153A1 (de) * | 1998-10-01 | 2000-04-06 | Merck Patent Gmbh | Imidazo[4,5]-pyridin-4-on-derivate |
FR2784679B1 (fr) | 1998-10-06 | 2001-03-30 | Rhodia Chimie Sa | Silanes et polyorganosiloxanes a fonction(s) boronate |
US6271380B1 (en) | 1998-12-30 | 2001-08-07 | Dupont Pharmaceuticals Company | 1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands |
EP1142895B1 (en) | 1999-01-08 | 2006-07-05 | Chisso Corporation | Borane derivatives and organic electroluminescents |
DE19900471A1 (de) | 1999-01-08 | 2000-07-13 | Merck Patent Gmbh | Imidazo[4,5c]-pyridin-4-on-derivate |
CA2373073A1 (en) * | 1999-05-07 | 2000-11-16 | Takeda Chemical Industries, Ltd. | Cyclic compounds and uses thereof |
US6844367B1 (en) * | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
US6770666B2 (en) * | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
CN1167680C (zh) | 1999-12-27 | 2004-09-22 | 日本烟草产业株式会社 | 稠环化合物及其药物用途 |
WO2001060315A2 (en) | 2000-02-18 | 2001-08-23 | Shire Biochem Inc. | Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
CA2401778C (en) * | 2000-02-29 | 2010-12-21 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
EP1132381A1 (en) * | 2000-03-08 | 2001-09-12 | Cermol S.A. | Ester derivatives of dimethylpropionic acid and pharmaceutical compositions containing them |
WO2001085172A1 (en) | 2000-05-10 | 2001-11-15 | Smithkline Beecham Corporation | Novel anti-infectives |
US6448281B1 (en) * | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP1355916B1 (en) | 2001-01-22 | 2007-01-10 | Merck & Co., Inc. | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
JP4331944B2 (ja) | 2001-04-17 | 2009-09-16 | 大日本住友製薬株式会社 | 新規アデニン誘導体 |
AR035543A1 (es) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
US20030073836A1 (en) * | 2001-07-05 | 2003-04-17 | Boehringer Ingelheim Pharma Kg | Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
JP4558314B2 (ja) | 2001-07-20 | 2010-10-06 | ベーリンガー インゲルハイム (カナダ) リミテッド | ウイルスポリメラーゼインヒビター |
EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
US7294457B2 (en) * | 2001-08-07 | 2007-11-13 | Boehringer Ingelheim (Canada) Ltd. | Direct binding assay for identifying inhibitors of HCV polymerase |
DE10140246A1 (de) * | 2001-08-09 | 2003-03-06 | Forsch Pigmente Und Lacke E V | Verfahren zur Behandlung von Oberflächen von Substraten |
WO2003026587A2 (en) | 2001-09-26 | 2003-04-03 | Bristol-Myers Squibb Company | Compounds useful for treating hepatitus c virus |
AU2003205570A1 (en) | 2002-01-10 | 2003-07-24 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs |
GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
US7362349B2 (en) * | 2002-07-10 | 2008-04-22 | Seiko Epson Corporation | Multi-participant conference system with controllable content delivery using a client monitor back-channel |
EP2308878A3 (de) | 2002-08-21 | 2011-10-26 | Boehringer Ingelheim Pharma GmbH & Co. KG | 8-[3-Amino-Piperidin-1-YL] -Xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
JP4619786B2 (ja) * | 2002-08-29 | 2011-01-26 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための3−(スルホンアミドエチル)−インドール誘導体 |
WO2004054974A2 (en) * | 2002-12-13 | 2004-07-01 | Smithkline Beecham Corporation | Piperidine derivatives as ccr5 antagonists |
US7098231B2 (en) * | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7223785B2 (en) * | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
DE602004022633D1 (de) | 2003-01-30 | 2009-10-01 | Boehringer Ingelheim Pharma | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen |
US7566707B2 (en) * | 2003-06-18 | 2009-07-28 | Boehringer Ingelheim International Gmbh | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
BRPI0416283A (pt) * | 2003-11-05 | 2007-01-23 | Hoffmann La Roche | compostos, processo para a fabricação de compostos, composição farmacêutica, método para o tratamento e/ou prevenção de doenças que são moduladas por agonistas de ppar(delta) e/ou ppar(alfa) e uso destes compostos |
US20050222198A1 (en) | 2003-12-22 | 2005-10-06 | K.U. Leuven Research & Development, Gerhard Puerstinger And Gilead Sciences, Inc. | Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
JP5014129B2 (ja) | 2004-07-27 | 2012-08-29 | ギリアード サイエンシーズ, インコーポレイテッド | イミダゾ[4,5−d]ピリミジン、それらの使用および調製方法 |
WO2006029966A1 (en) | 2004-09-13 | 2006-03-23 | Ciba Specialty Chemicals Holding Inc. | Alkylaminoacetamide lubricant additives |
ES2324794T3 (es) * | 2004-12-21 | 2009-08-14 | Gilead Sciences Inc | Imidazo(4,5-c)pyridine componente y metodo de tratamiento antiviral. |
PT2038275E (pt) * | 2006-07-07 | 2010-04-08 | Puerstinger Gerhard | Novo composto de piridazina e sua utilização |
UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
-
2002
- 2002-07-03 GB GBGB0215293.2A patent/GB0215293D0/en not_active Ceased
-
2003
- 2003-07-03 CN CNB038201429A patent/CN1328279C/zh not_active Expired - Fee Related
- 2003-07-03 EP EP03762361A patent/EP1521754B1/en not_active Expired - Lifetime
- 2003-07-03 ES ES10182308.6T patent/ES2525483T3/es not_active Expired - Lifetime
- 2003-07-03 DK DK03762361.8T patent/DK1521754T3/da active
- 2003-07-03 EA EA200500150A patent/EA013562B1/ru not_active IP Right Cessation
- 2003-07-03 SI SI200332077T patent/SI1521754T1/sl unknown
- 2003-07-03 NZ NZ537473A patent/NZ537473A/en not_active IP Right Cessation
- 2003-07-03 IL IL166055A patent/IL166055A/en not_active IP Right Cessation
- 2003-07-03 WO PCT/BE2003/000117 patent/WO2004005286A2/en active Application Filing
- 2003-07-03 BR BR122018077110-0A patent/BR122018077110B1/pt not_active IP Right Cessation
- 2003-07-03 KR KR1020047021644A patent/KR101184032B1/ko not_active IP Right Cessation
- 2003-07-03 EP EP10182308.6A patent/EP2332938B1/en not_active Expired - Lifetime
- 2003-07-03 BR BRPI0312547A patent/BRPI0312547B8/pt not_active IP Right Cessation
- 2003-07-03 PT PT03762361T patent/PT1521754E/pt unknown
- 2003-07-03 JP JP2004518295A patent/JP4907082B2/ja not_active Expired - Fee Related
- 2003-07-03 PT PT101823086T patent/PT2332938E/pt unknown
- 2003-07-03 CA CA2491243A patent/CA2491243C/en not_active Expired - Fee Related
- 2003-07-03 KR KR1020117001338A patent/KR101131591B1/ko not_active IP Right Cessation
- 2003-07-03 ES ES03762361T patent/ES2372277T3/es not_active Expired - Lifetime
- 2003-07-03 US US10/519,756 patent/US7737162B2/en active Active
- 2003-07-03 AU AU2003243846A patent/AU2003243846B9/en not_active Ceased
- 2003-07-03 AT AT03762361T patent/ATE522528T1/de active
- 2003-07-03 MX MXPA04012965A patent/MXPA04012965A/es active IP Right Grant
-
2004
- 2004-12-30 NO NO20045731A patent/NO330766B1/no not_active IP Right Cessation
-
2006
- 2006-02-15 HK HK06101965A patent/HK1082734A1/xx not_active IP Right Cessation
-
2009
- 2009-02-19 AU AU2009200648A patent/AU2009200648B2/en not_active Ceased
- 2009-05-19 US US12/468,667 patent/US8779141B2/en active Active
-
2010
- 2010-08-03 JP JP2010174929A patent/JP5174097B2/ja not_active Expired - Fee Related
-
2011
- 2011-11-11 CY CY20111101084T patent/CY1112042T1/el unknown
- 2011-12-07 HK HK11113246.2A patent/HK1161231A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE522528T1 (de) | Virale inhibitoren | |
ATE491459T1 (de) | Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation | |
DK1719773T3 (da) | Kondenserede heterotetracykliske forbindelser og anvendelse deraf som HCV-polymeraseinhibitor | |
CO5630024A2 (es) | Compuestos inhibidores de la hepatitis c | |
MXPA05006196A (es) | Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus. | |
ATE512976T1 (de) | Hemmer des hepatitis-c-virus | |
PL376409A1 (en) | Composition for the treatment of infection by flaviviridae viruses | |
BRPI0515596A (pt) | composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero | |
WO2004009020A3 (en) | Pyrrolopyrimidine thionucleoside analogs as antivirals | |
BR0309581A (pt) | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c | |
NZ595000A (en) | Imidazo[4,5-c]pyridine derivative for treating viral infections | |
MY164469A (en) | Hcv ns3 protease inhibitors | |
HK1112910A1 (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
SG164376A1 (en) | Hcv ns3 protease inhibitors | |
NO20062146L (no) | Nukleosidforbindelser for behandling av virusinfeksjoner | |
TW200518746A (en) | Novel inhibitors of hepatitis C virus NS3/NS4A serine protease | |
ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus | |
ATE493408T1 (de) | Antiinfektiöse mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: K.U. LEUVEN RESEARCH AND DEVELOPMENT (BE) ; GERHAR |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/01/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/07/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |